Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
AGUIAR-LUCANDER, Renee
To:Pharmalink AB, CEO (May)
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Abivax reflects on a transformative year marked by landmark clinical success and ambitious plans for the future.
Launched in April 2025, Astellas’s Innovation Lab unites fragmented research units under Morten Sogaard to pursue focused indications, a dual-track R&D strategy and tailored partnerships that balance innovation, risk and collaboration.
Resmed’s CMO Carlos Nunez discusses the sleep giant’s continued push from medtech into healthtech and its efforts to fix what he calls a “broken pathway” to diagnosis and treatment for millions with undetected sleep apnea.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Recursion recently announced the completion of a $30m microglia map and named Najat Khan as CEO, replacing co-founder Chris Gibson.
Patient advocacy organizations are transforming gene therapy development by funding research, de-risking programs and driving ultra-rare disease treatments from concept to clinic at unprecedented speed.
